843
Views
5
CrossRef citations to date
0
Altmetric
Brief Report

Inquiry into the short- and long-term effects of Roux-en-Y gastric bypass on the glomerular filtration rate

, & ORCID Icon
Pages 624-628 | Received 10 Mar 2020, Accepted 25 Jun 2020, Published online: 13 Jul 2020

References

  • Chagnac A, Zingerman B, Rozen-Zvi B, et al. Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron. 2019;143(1):38–35.
  • Friedman AN, Moe S, Fadel WF, et al. Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol. 2014;39(1):8–15.
  • Martin WP, Le Roux CW. Comment on: metabolic surgery improves renal injury independent of weight loss: a meta-analysis. Surg Obes Relat Dis. 2019;15(6):1020–1023.
  • Neff KJ, Elliott JA, Corteville C, et al. Effect of Roux-en-Y gastric bypass and diet-induced weight loss on diabetic kidney disease in the Zucker diabetic fatty rat. Surg Obes Relat Dis. 2017;13(1):21–27.
  • Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–242.
  • Muskiet MHA, Tonneijck L, Smits MM, et al. GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes. Nat Rev Nephrol. 2017;13(10):605–628.
  • von Scholten BJ, Persson F, Rosenlund S, et al. The effect of liraglutide on renal function: a randomized clinical trial. Diabetes Obes Metab. 2017;19(2):239–247.
  • Asmar A, Simonsen L, Asmar M, et al. Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy. Am J Physiol Endocrinol Metab. 2016;310(9):E744–53.
  • Muskiet MH, Tonneijck L, Smits MM, et al. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men. Diabetes Obes Metab. 2016;18(2):178–185.
  • Gutzwiller JP, Tschopp S, Bock A, et al. Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. J Clin Endocrinol Metab. 2004;89(6):3055–3061.
  • Shankar SS, Mixson LA, Chakravarthy M, et al. Metabolic improvements following Roux-en-Y surgery assessed by solid meal test in subjects with short duration type 2 diabetes. BMC Obes. 2017;4:10.
  • Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care. 2016;39(6):893–901.
  • Friedman AN, Yu Z, Juliar BE, et al. Independent influence of dietary protein on markers of kidney function and disease in obesity. Kidney Int. 2010;78(7):693–697.
  • D'Agati VD, Chagnac A, de Vries AP, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–471.
  • Zingerman B, Herman-Edelstein M, Erman A, et al. Effect of acetazolamide on obesity-induced glomerular hyperfiltration: a randomized controlled trial. PLoS One. 2015;10(9):e0137163.
  • Docherty NG, Fandriks L, Le Roux CW, et al. Urinary sodium excretion after gastric bypass surgery. Surg Obes Relat Dis. 2017;13(9):1506–1514.